Back to Journals » Infection and Drug Resistance » Emerging Trends in Multidrug-Resistant Infections
Infection and Drug Resistance
- View all (4933)
- Volume 19, 2026 (375)
- Volume 18, 2025 (601)
- Volume 17, 2024 (563)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Journal Articles:
- Personalized Antimicrobial Strategies: A Path to Precision Therapy (4)
- Emerging Trends in Multidrug-Resistant Infections (7)
- Unlocking Drug Resistance Prediction with AI (3)
- Antimicrobial Stewardship and Infection Control: A Global Perspective (4)
- Advances in Prosthetic Joint Infections: Current Challenges and Future Solutions (2)
- Current aspects of fungal infections (1)
- Advances in Osteomyelitis: Pathogenesis, Diagnosis, and Treatment (1)
- Respiratory Syncytial Virus (RSV): progress, challenges and outcomes (6)
Emerging Trends in Multidrug-Resistant Infections
Multidrug-resistant infections represent a critical global health crisis, posing significant threats to public health, economics, and patient safety. As resistance to antibiotics increases, healthcare providers face a diminishing arsenal of effective treatments, complicating the management of infections and leading to higher morbidity and mortality rates. This situation results in longer hospital stays and increased medical costs, imposing a substantial economic burden on healthcare systems. Vulnerable populations, such as the elderly and immunocompromised individuals, are particularly at risk, underscoring the urgency to confront this challenge.
Molecular Diagnostics, Antimicrobial Resistance Patterns, and Clinical Outcomes in Hospitalized Pneumonia Patients: A Prospective Study from Jordan and a Call for National Guideline Integration
Alsayed AR, Zihlif M, Abuata OM, Permana AD, Zihlif M
Infection and Drug Resistance 2026, 19:585095
Published Date: 26 February 2026
Sociodemographic and Clinical Correlates of Multidrug-Resistant Uropathogens in Hospitalized Children
Muhsen K, Haleem S, Mansour B, Shapira M, Pitashny M, Masarwa M, Omar M, Na’aminh W, Kassem E
Infection and Drug Resistance 2026, 19:588989
Published Date: 8 April 2026
Addressing Antimicrobial Resistance: A Point Prevalence Survey Using AWaRe Indicators from Outpatient Settings of Multan, Pakistan
Alam M, Rasool MF, Haseeb A, Altowayan WM, Alqasoumi A, Khakwani M, Saleem Z
Infection and Drug Resistance 2026, 19:592798
Published Date: 28 May 2026
Impact of Drug-Resistant Tuberculosis Prevention and Control Strategies in Southeast China: Evidence from a Longitudinal Study on Disease Epidemic Trends and Predictions Across 15 Years
Wu Y, Li M, Zhu Y, Peng Y, Wang F, Chen X, Zu Z, Chen B, Zhou L, Chen D
Infection and Drug Resistance 2026, 19:597234
Published Date: 17 April 2026
Root Cause Analysis for Outbreaks of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa in a Pediatric Intensive Care Unit: A Retrospective Study
Peng W, Hao Y, Ding H, Wang Z, Tan K, Tan L
Infection and Drug Resistance 2026, 19:598824
Published Date: 22 May 2026
Legionellosis: Global Epidemiology and Current Perspectives on Diagnosis and Treatment
Ma J, Dong T, Li F, He C, Li B, Liu Z
Infection and Drug Resistance 2026, 19:603565
Published Date: 9 April 2026
Correlation Between Xpert MTB/RIF Results and rpoB Mutations within Probe-Targeted Regions in Mycobacterium tuberculosis Isolates from Sichuan Basin
Li K, Li L
Infection and Drug Resistance 2025, 18:5161-5171
Published Date: 29 September 2025